NCT02996565

Brief Summary

This pragmatic trial will compare two team-based care models for managing hypertension, Best Practice Clinic-based Care and Telehealth Care with pharmacist management, in a large care system in Minnesota. Clinics in the study are randomized to offer one of the two treatment models to participants with uncontrolled hypertension. The investigators aim to determine a) whether one model is more effective than the other for lowering patient's blood pressure and b) which model patients prefer.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
3,071

participants targeted

Target at P75+ for not_applicable hypertension

Timeline
Completed

Started Nov 2017

Longer than P75 for not_applicable hypertension

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 12, 2016

Completed
7 days until next milestone

First Posted

Study publicly available on registry

December 19, 2016

Completed
11 months until next milestone

Study Start

First participant enrolled

November 15, 2017

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 17, 2020

Completed
1.2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2021

Completed
3.2 years until next milestone

Results Posted

Study results publicly available

September 23, 2024

Completed
Last Updated

September 23, 2024

Status Verified

December 1, 2020

Enrollment Period

2.4 years

First QC Date

December 12, 2016

Results QC Date

November 22, 2022

Last Update Submit

May 7, 2024

Conditions

Keywords

Clinic careTeam-based careMedication Therapy Management (MTM)TelehealthCluster-randomizedHome blood pressure monitoringPharmacist

Outcome Measures

Primary Outcomes (1)

  • Change in Systolic Blood Pressure Between Baseline and 12 Months (mm Hg)

    Change in systolic BP, collected from medical records

    Trajectory over 12 months

Secondary Outcomes (29)

  • Change in Diastolic BP Between Baseline and 12 Months (mm Hg)

    Trajectory over 12 months

  • Number of Participants Who Reporting Monitoring BP at Least 2 Times Per Week at Six Months Follow-up

    Baseline to 6 months

  • Number of Participants Who Report High Level of Satisfaction With Hypertension Care at Six Months.

    Baseline to 6 months

  • Number of Participants Who Are Current Smokers at Twelve Months

    Baseline to 12 months

  • Number of Participants Reporting Cough as a Side Effect of Antihypertensive Medications at Six Months

    Baseline to 6 months

  • +24 more secondary outcomes

Study Arms (2)

Best Practice Clinic-Based Care

ACTIVE COMPARATOR

Patients with uncontrolled hypertension who receive primary care in clinics assigned to the Best Practice Clinic-Based Care intervention.

Other: Best Practice Clinic-Based Care

Telehealth Care

ACTIVE COMPARATOR

Patients with uncontrolled hypertension who receive primary care in clinics assigned to the Telehealth Care intervention.

Other: Telehealth Care

Interventions

Relies primarily on the physician-medical assistant dyad and face-to-face visits to promote: 1. Improved recognition of uncontrolled BP at primary care encounters, 2. Therapeutic action to address uncontrolled BP at primary care encounters, 3. Reliable follow-up visits to re-assess uncontrolled BP every 2-4 weeks.

Best Practice Clinic-Based Care

All elements of Clinic-Based Care are performed, plus a telemonitoring and pharmacist case management program is offered, specifically: 1. Referral to care by MTM pharmacist or Nurse Practitioner and receiving a home blood pressure telemonitoring device 2. Systematic home BP telemonitoring with data transmitted into patient medical record 3. Systematic home-based care by pharmacist or nurse practitioner via telephone and/or secure email

Telehealth Care

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Hypertension diagnosis code in medical record, twice in last 24 months
  • Attends study clinic for primary care visit within study period with uncontrolled blood pressure
  • Systolic blood pressure \>=150 mm Hg or Diastolic blood pressure \>=95 mm Hg at current visit
  • Systolic blood pressure \>=150 mm Hg or Diastolic blood pressure \>=95 mm Hg at most recent previous visit

You may not qualify if:

  • Pregnancy
  • End Stage Kidney Disease
  • Patients in hospice care and patients who permanently reside in a nursing home

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

HealthPartners Institute

Bloomington, Minnesota, 55425, United States

Location

Related Publications (6)

  • Margolis KL, Crain AL, Pawloski PA, Ziegenfuss JY, Trower NK, Bergdall AR, Beran M, Norton CK, Haugen PK, Rehrauer DJ, Green BB, Solberg LI, Sperl-Hillen JM. Blood Pressure Medication Side Effect Symptoms and Patient Treatment Satisfaction and Adherence. J Am Board Fam Med. 2025 Mar-Apr;38(2):312-329. doi: 10.3122/jabfm.2024.240288R1.

  • Margolis KL, Bergdall AR, Crain AL, JaKa MM, Anderson JP, Solberg LI, Sperl-Hillen J, Beran M, Green BB, Haugen P, Norton CK, Kodet AJ, Sharma R, Appana D, Trower NK, Pawloski PA, Rehrauer DJ, Simmons ML, McKinney ZJ, Kottke TE, Ziegenfuss JY, Williams RA, O'Connor PJ. Comparing Pharmacist-Led Telehealth Care and Clinic-Based Care for Uncontrolled High Blood Pressure: The Hyperlink 3 Pragmatic Cluster-Randomized Trial. Hypertension. 2022 Dec;79(12):2708-2720. doi: 10.1161/HYPERTENSIONAHA.122.19816. Epub 2022 Oct 25.

  • JaKa M, Bergdall A, Beran MS, Solberg L, Green BB, Andersen J, Kodet A, Norman S, Haugen P, Crain L, Trower N, Sharma R, Rehrauer D, Maeztu C, Margolis K. Reach in a pragmatic hypertension trial: A critical RE-AIM component. Contemp Clin Trials. 2022 Oct;121:106896. doi: 10.1016/j.cct.2022.106896. Epub 2022 Aug 24.

  • Margolis KL, Crain AL, Green BB, O'Connor PJ, Solberg LI, Beran M, Bergdall AR, Pawloski PA, Ziegenfuss JY, JaKa MM, Appana D, Sharma R, Kodet AJ, Trower NK, Rehrauer DJ, McKinney Z, Norton CK, Haugen P, Anderson JP, Crabtree BF, Norman SK, Sperl-Hillen JM. Comparison of explanatory and pragmatic design choices in a cluster-randomized hypertension trial: effects on enrollment, participant characteristics, and adherence. Trials. 2022 Aug 17;23(1):673. doi: 10.1186/s13063-022-06611-3.

  • Solberg LI, Crain AL, Green BB, Ziegenfuss JY, Beran MS, Sperl-Hillen JM, Norton CK, Margolis KL. Experiences and Perceptions of Patients with Uncontrolled Hypertension Who are Dissatisfied with Their Hypertension Care. J Am Board Fam Med. 2021 Nov-Dec;34(6):1115-1122. doi: 10.3122/jabfm.2021.06.210240.

  • Margolis KL, Crain AL, Bergdall AR, Beran M, Anderson JP, Solberg LI, O'Connor PJ, Sperl-Hillen JM, Pawloski PA, Ziegenfuss JY, Rehrauer D, Norton C, Haugen P, Green BB, McKinney Z, Kodet A, Appana D, Sharma R, Trower NK, Williams R, Crabtree BF. Design of a pragmatic cluster-randomized trial comparing telehealth care and best practice clinic-based care for uncontrolled high blood pressure. Contemp Clin Trials. 2020 May;92:105939. doi: 10.1016/j.cct.2020.105939. Epub 2020 Jan 22.

MeSH Terms

Conditions

Hypertension

Interventions

Telemedicine

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Delivery of Health CarePatient Care ManagementHealth Services Administration

Results Point of Contact

Title
Karen Margolis, MD MPH
Organization
HealthPartners Institute

Study Officials

  • Karen Margolis, MD

    HealthPartners Institution

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 12, 2016

First Posted

December 19, 2016

Study Start

November 15, 2017

Primary Completion

April 17, 2020

Study Completion

June 30, 2021

Last Updated

September 23, 2024

Results First Posted

September 23, 2024

Record last verified: 2020-12

Data Sharing

IPD Sharing
Will share

We will provide a de-identified, individual-level dataset to PCORI if requested at the end of the study. The dataset will be made publicly available and will contain no identifying information.

Locations